CE
CERo Therapeutics Holdings, Inc.
CEROW · OTC
$0.00 +182.35% (+$0.00)
1M +117.65%
Market Cap $101.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 388.91%
ROA 547.09%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.30x
Debt/Equity N/A
Int. coverage N/A
Stability
1 /100
Unstable Beta 0.16x
EPS volatility 7,214.36%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na CEROW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher Ehrlich
Employees
8
Headquarters
South San Francisco
Nadcházející události
02 PRO
Earnings
Upcoming earnings report